Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04022876
Title A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)
Recruitment Active, not recruiting
Gender
Phase Phase I
Variant Requirements Yes
Sponsors Aileron Therapeutics, Inc.
Indications

lung adenocarcinoma

lung non-small cell carcinoma

lung small cell carcinoma

Therapies

ALRN-6924 + Carboplatin + Pemetrexed Disodium

ALRN-6924 + Topotecan

Carboplatin + Pemetrexed Disodium

Age Groups: senior | adult
Covered Countries USA | ITA | ESP | DEU

Additional content available in CKB BOOST